全部 标题 作者
关键词 摘要


Bevacizumab vs. Ranibizumab in Preserving or Improving Vision in Patients with Wet, Age-Related Macular Degeneration: A Cost-effectiveness Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text

comments powered by Disqus